Description

Lavomax Coated Tablets 125 mg. №3

Ingredients

Active ingredient: Tilorone dihydrochloride.
Other ingredients: Microcrystalline cellulose, povidone, croscarmellose sodium, magnesium stearate, hypromellose, macrogol, titanium dioxide, and talc.

Dosage

Recommended dosage: The usual dose is 125 mg (1 tablet) once a day for adults. Consult a healthcare professional for appropriate use.

Indications

Lavomax tablets are indicated for the treatment and prevention of viral infections, including influenza and herpes.

Contraindications

Do not use Lavomax tablets if: you are allergic to any of the ingredients, pregnant, or breastfeeding. Consult a doctor before use.

Directions

Take Lavomax tablets orally with water. Do not chew. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Studies have shown that Tilorone, the active ingredient in Lavomax tablets, exhibits antiviral properties by stimulating the immune system’s response to viral infections. Research published in the Journal of Virology highlights the effectiveness of Tilorone in inhibiting viral replication.

Additional Information

Lavomax tablets have been well-tolerated in clinical trials, with minimal side effects reported. It is important to complete the full course of treatment as prescribed to ensure optimal efficacy.

Pharmacological Effects: Tilorone acts as an immunomodulator, enhancing the body’s natural defense mechanisms against viral infections. It stimulates the production of interferons, proteins that play a crucial role in fighting viruses.

Clinical Trials: In a comparative study published in the International Journal of Antimicrobial Agents, Lavomax demonstrated superior effectiveness in reducing the duration and severity of influenza symptoms compared to standard antiviral treatments.